Drugs / Secretrol
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01905202 | Apr 2013 → Apr 2015 | Barrett esophagus | Effexus Pharmaceutical | Unknown | No outcome recorded |
| Phase 1 | NCT02210494 | Apr 2013 → Aug 2015 | ulcer disease | Effexus Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Secretrol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01905202 ↗ |